← Back to Search

Shared Decision-Making Education for Prostate Cancer Screening

N/A
Waitlist Available
Led By Margarita Echeverri, PhD, MSc
Research Sponsored by Xavier University of Louisiana.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial is testing whether an educational intervention can help African American males make more informed decisions about prostate cancer screening.

Who is the study for?
This trial is for African American men aged 40-69 who are receiving care at specific clinical sites and have not been previously diagnosed with prostate cancer. It's not suitable for those unable to complete the study in time or with cognitive impairments affecting participation.Check my eligibility
What is being tested?
The trial tests an educational program designed to improve conversations between doctors and African American men about PSA screening for prostate cancer. Participants will either receive this multimedia intervention or stick with the usual care practices.See study design
What are the potential side effects?
Since this is an educational intervention, there are no direct medical side effects like you'd expect from a drug. However, participants may experience stress or anxiety related to discussions about their health choices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Shared decision-making
Secondary outcome measures
Preference-Congruent Decision Making
Quality of Decision (QD)
Other outcome measures
Acceptability

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Patients in the intervention will receive the educational intervention
Group II: Usual CareActive Control1 Intervention
Patients in the control arm will receive usual care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Shared Decision-Making Intervention
2020
N/A
~170

Find a Location

Who is running the clinical trial?

Xavier University of Louisiana.Lead Sponsor
6 Previous Clinical Trials
2,667 Total Patients Enrolled
Tulane UniversityOTHER
115 Previous Clinical Trials
226,341 Total Patients Enrolled
Margarita Echeverri, PhD, MScPrincipal InvestigatorXavier University of Louisiana.

Media Library

Educational Shared Decision-Making Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03869216 — N/A
Prostate Cancer Research Study Groups: Usual Care, Intervention
Prostate Cancer Clinical Trial 2023: Educational Shared Decision-Making Intervention Highlights & Side Effects. Trial Name: NCT03869216 — N/A
Educational Shared Decision-Making Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03869216 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research permit senior citizens to participate?

"This particular medical trial is recruiting patients aged 40 to 69. By contrast, there are 76 trials aimed at those under 18 and 1316 clinical trials available for individuals over 65."

Answered by AI

Is this trial still open to new participants?

"This treatment trial, which was initially posted on August 17th 2020 and last updated October 13th 2021, is not presently open to participants. However, a plethora of other trials are recruiting patients at this time with thirteen hundred twenty two in total."

Answered by AI

Could I potentially participate in this medical experiment?

"This medical study is searching for 200 African American males, aged 40 to 69 years old, who currently receive care at the clinical sites and have been diagnosed with prostate cancer."

Answered by AI
~34 spots leftby Apr 2025